Applications and safety of gold nanoparticles as therapeutic devices in clinical trials
Journal of Pharmaceutical Analysis · 2023-09 · 13 (9) · 960-967
DOI: 10.1016/j.jpha.2023.06.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical Analysis, 2023-09. Verfasst von Leeann Yao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Latner Thoracic Surgical Research Laboratories, Toronto General Hospital Research Institute, University Health Network, Toronto, ON, M5G 1L7, Canada. Die Arbeit wurde bisher 130-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Latner Thoracic Surgical Research Laboratories, Toronto General Hospital Research Institute, University Health Network, Toronto, ON, M5G 1L7, Canada.
- Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, M5S 1A8, Canada.
- Department of Surgery, Medicine and Physiology, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, M5S 1A8, Canada.
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Yao, L., Bojic, D., & Liu, M. (2023). Applications and safety of gold nanoparticles as therapeutic devices in clinical trials. Journal of Pharmaceutical Analysis, 13(9), 960-967. https://doi.org/10.1016/j.jpha.2023.06.001
Vancouver
Yao L, Bojic D, Liu M. Applications and safety of gold nanoparticles as therapeutic devices in clinical trials. Journal of Pharmaceutical Analysis. 2023;13(9):960-967. doi:10.1016/j.jpha.2023.06.001
BibTeX
@article{Yao2023,
author = {Yao, Leeann and Bojic, Dejan and Liu, Mingyao},
title = {Applications and safety of gold nanoparticles as therapeutic devices in clinical trials},
journal = {Journal of Pharmaceutical Analysis},
year = {2023},
volume = {13},
number = {9},
pages = {960--967},
doi = {10.1016/j.jpha.2023.06.001}
}
EUVIMED